GMAB
Genmab A/S
$28.61
-$0.06(-0.21%)
46
Overall
60
Value
36
Tech
42
Quality
Market Cap
$19.28B
Volume
1.57M
52W Range
$17.24 - $33.65
Target Price
$35.85
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|
| REVENUE | |||||
| Total Revenue | $14.5B | $16.5B | $21.5B | ||
| Total Revenue | $14.5B | $16.5B | $21.5B | ||
| COST OF GOODS SOLD | |||||
| Cost of Revenue | -- | $226.0M | $985.0M | ||
| GROSS PROFIT | |||||
| Gross Profit | $14.5B | $16.2B | $20.5B | ||
| OPERATING EXPENSES | |||||
| Operating Expenses | $8.2B | $10.9B | $13.8B | ||
| Research & Development | $5.6B | $7.6B | $9.7B | ||
| Research Expense | $5.6B | $7.6B | $9.7B | ||
| Selling, General & Administrative | $2.7B | $3.3B | $3.8B | ||
| Selling & Marketing Expenses | $2.7B | $3.3B | $3.8B | ||
| OPERATING INCOME | |||||
| Operating income | $6.3B | $5.3B | $6.7B | ||
| EBITDA | $8.6B | $6.3B | $10.0B | ||
| NON-OPERATING ITEMS | |||||
| Interest Expense (Non-Operating) | $-21.0M | $344.0M | $383.0M | ||
| Intinc | $324.0M | $1.5B | $1.5B | ||
| Net Non-Operating Interest Income/Expense | $1.0B | $316.0M | $2.5B | ||
| Gain on Sale of Securities | $-659.0M | -- | -- | ||
| Other Income/Expense | $659.0M | $-596.0M | -- | ||
| PRE-TAX INCOME | |||||
| EBIT | $8.3B | $6.0B | $9.5B | ||
| Pre-Tax Income | $8.3B | $5.6B | $9.2B | ||
| INCOME TAX | |||||
| Tax Provision | $1.5B | $1.3B | $1.3B | ||
| NET INCOME | |||||
| Net Income | $6.8B | $4.4B | $7.8B | ||
| Net Income (Continuing Operations) | $6.8B | $4.4B | $7.8B | ||
| Net Income (Discontinued Operations) | $6.8B | $4.4B | $7.8B | ||
| Net Income (Common Stockholders) | $6.8B | $4.4B | $7.8B | ||
| Normalized Income | $6.1B | $4.1B | $9.4B | ||
| TOTALS | |||||
| Total Expenses | $8.2B | $11.2B | $14.8B | ||
| SHARE & EPS DATA | |||||
| Average Shares Outstanding | $65.4M | $65.3M | -- | ||
| Average Shares Outstanding (Diluted) | $66.0M | $65.9M | -- | ||
| Shares Outstanding | $661.9M | $661.9M | $661.9M | ||
| Basic EPS | $83.38 | $66.64 | -- | ||
| Basic EPS (Continuing Operations) | $83.38 | $66.64 | -- | ||
| Diluted EPS | $82.59 | $66.02 | -- | ||
| Diluted EPS (Continuing Operations) | $82.59 | $66.02 | -- | ||
| OTHER METRICS | |||||
| Acquisition Expense | -- | -- | $300.0M | ||
| Development Expense | $1.6B | -- | -- | ||
| Other Costof Revenue | -- | $226.0M | $985.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GMAB | $28.61 | -0.2% | 1.57M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |